Every news event mapped to its market reaction — 5 events, 2 months of data. No predictions, just what happened.
Want the full written briefing?
The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.
| Date | Return | Category | Source | Headline |
|---|---|---|---|---|
| 2026-03-31 | -3.7% | analyst | MT Newswires | HC Wainwright Initiates Coverage on Envoy Medical With Buy Rating, $2.50 Price Target |
| 2026-04-16 | -1.5% | executive | TMX Newsfile | Envoy Medical Appoints Chas McKhann to Board of Directors |
| 2026-04-01 | -0.8% | news | TMX Newsfile | Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant |
| 2026-03-23 | -0.7% | news | TMX Newsfile | Envoy Medical Reports Full Year 2025 Financial Results |
| 2026-04-22 | -0.6% | news | TMX Newsfile | Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant |